The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 24, 2017

Filed:

Jun. 15, 2012
Applicants:

Tohru Tanaka, Tokyo, JP;

Katsushi Inoue, Tokyo, JP;

Kiwamu Takahashi, Tokyo, JP;

Takuya Ishii, Tokyo, JP;

Tsutomu Numata, Chiba, JP;

Mariko Shibuya, Chiba, JP;

Takeshi Suzuki, Chiba, JP;

Inventors:

Tohru Tanaka, Tokyo, JP;

Katsushi Inoue, Tokyo, JP;

Kiwamu Takahashi, Tokyo, JP;

Takuya Ishii, Tokyo, JP;

Tsutomu Numata, Chiba, JP;

Mariko Shibuya, Chiba, JP;

Takeshi Suzuki, Chiba, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 5/06 (2006.01); A61K 9/06 (2006.01); A61K 41/00 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61N 5/062 (2013.01); A61K 9/0043 (2013.01); A61K 9/06 (2013.01); A61K 41/0061 (2013.01); F04C 2270/0421 (2013.01);
Abstract

Provided is a therapeutic agent capable of treating allergic rhinitis in a safe, simple, and noninvasive manner substantially without side effects and physical distress to patients. Provided is a therapeutic agent for allergic rhinitis for 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) comprising 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of the 5-aminolevulinic acid or the derivative as an active ingredient, and used in ALA-PDT in which light having a wavelength of 400 nm to 700 nm is irradiated; and particularly provided is a therapeutic agent for allergic rhinitis in a locally applied solution form, a water-soluble ointment-dissolved form, a jelly-dissolved form, or the like. The therapeutic agent does not require the conduct of 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD) for detecting a site of protoporphyrin IX (PpIX) accumulation radiating light having a wavelength of 610 nm to 650 nm under irradiation of excitation light having a wavelength of 380 nm to 420 nm before ALA-PDT.


Find Patent Forward Citations

Loading…